Human papillomavirus vaccine acceptance among young men in Bangalore, India

Abstract

Background Human papillomavirus (HPV) is the most common sexually transmitted infection in the world. It can lead to anogenital, cervical, and head and neck cancer, with higher risk of malignant disease in patients with human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS) patients. In India, 73,000 of the 130,000 women diagnosed with cervical cancer die annually. Gardasil®, a vaccine available against HPV types 6, 11, 16, and 18, is approved for use in women in India but not men. A backlash to post-licensure trials has created a negative public opinion of the vaccine for women. Vaccinating boys and men is an alternate approach to prevent cervical cancer in women. This study gauges facilitators and barriers to vaccination acceptance among men in Bangalore, India. Materials and methods Young men presenting to a dermatology clinic or an ART center in Bangalore, India, answered a seven-point survey assessing acceptance of the HPV vaccine, perceived barriers to vaccination, and acceptance of vaccination for their children. Ninety-three general dermatology patients and 85 patients with HIV/AIDS participated. Results There was a high degree of vaccine acceptance for both groups, 83 and 98%, respectively. Vaccine side effects and cost were cited as key barriers to vaccination, and doctor recommendation and government approval were the main facilitators. Conclusion There is potential for high acceptability of the HPV vaccine among men in India. These results can facilitate further study of vaccine acceptance among males and physician opinion and knowledge about HPV vaccine use. Vaccination of males is a hopeful strategy to protect men and women from HPV-related malignancies.

Awareness of primary health care physicians about human papilloma virus infection and its vaccination: a cross-sectional survey from multiple clinics in Saudi Arabia

“… 17 A survey among young men visiting a dermatology clinic showed that there was a high level of HPV vaccine acceptance (83%), claiming that barriers to vaccination were mainly the cost and potential side effects, while a physician’s recommendation was the main facilitator. 18 Trust, knowledge, regard, and loyalty are four main elements in a physician–patient relationship. 19 For instance, the Guidance-Cooperation Model entails that the physician is placed in a position of power due to having the medical knowledge that the patient lacks on HPV infections.…”

Acceptance for Human Papilloma virus vaccines, experience at tertiary care centre of northern india: a hospital-based survey

“…Similar to present study Belani HK et al, in a study done in Bangalore concluded that high cost of the HPV vaccine acts as a barrier to vaccination (53%). 16 Because of the present high cost of the vaccine the affordability and accessibility of these vaccines is a major concern for a mass vaccination program in developing countries like India. But several studies found that there was no association between income and acceptance and major deterrents found in their study were concern about too many vaccinations, vaccine side effects, worry about increasing promiscuity.…”

Challenges of health promotion and education strategies to prevent cervical cancer in India: A systematic review

“…Overall, 77 papers and one dissertation were eligible for analysis and were listed in the order of publication years. [171819202122232425262728293031323334353637383940414243444546474849505152535455565758596061626364656667686970717273747576777879808182838485868788899091929394] The review process is explained in Figure 1.…”

“…The studies consist of different populations such as women and men from different community groups[17202425313235394143454751616669717379808586909293]And attended clinics[2729425259676872757682]Students (nursing/medical/paramedical/nonmedical)[3840464850565860646974818389]Health-care providers (doctors, nurses, and other health workers);[1828365354555657626365667778889194] migrated Indians;[1921262730333437498487] and cervical cancer patients. [23]…”